Lung Cancer
Colon Cancer
Breast Cancer
Prostate Cancer
Ovarian Cancer
Cervical Cancer
Pancreatic Cancer
Melanoma
Cancer (General)
Lung Cancer
Colon Cancer
Breast Cancer
Prostate Cancer
Ovarian Cancer
Cervical Cancer
Pancreatic Cancer
Melanoma
Lung Cancer
Colon Cancer
Breast Cancer
Prostate Cancer
Ovarian Cancer
Cervical Cancer
Pancreatic Cancer
Melanoma
Colleen Sullivan of Ashburn, store manager, dies at 55 Washington Post Colleen Sullivan, 55, a former hairdresser who became a manager at grocery stores and retail shops, died March 20 of ovarian cancer at Capital Hospice in ... |
EntreMed Raises Additional $3 Million to Further Support Clinical Development ... MarketWatch (press release) EntreMed recently announced the initiation of a Phase 2 study in ovarian cancer patients after encouraging Phase 1 results. Michael M. Tarnow, EntreMed's ... Headlines: InterMune reports Phase 1b MAD study results of RTV-boosted ... |
CORRECTING and REPLACING Tikcro Technologies Reports 2009 Fourth Quarter Results MarketWatch (press release) ... phase IIb clinical trial for the treatment of superficial bladder carcinoma cancer and a phase I/IIa clinical trial for the treatment of ovarian cancer. ... |
Scientists Find Gene Fault Behind Aggressive Ovarian Cancer Medical News Today (press release) Lead author Dr James Brenton, from Cancer Research UK's Cambridge Research Institute and an ovarian cancer clinician at Addenbrooke's Hospital, ... |
Scituate cancer survivor taking part in Avon walk Scituate Mariner So with renewed determination to fund breast cancer research, McGovern is participating in the walk again this year. During the walk, which takes place in ... |
Cancer survivors lead Relay for Life Times-Georgian Emily Fain, co-chairwoman of the event, is a six-year ovarian cancer survivor. “There are two times that get pretty emotional: The survivors' lap and the ... |
 Telegraph.co.uk | New drug hope for cancer sufferers Western Morning News It is being targeted at patients who have already developed an advanced form of breast or ovarian cancer and have been diagnosed with faults in the known ... Big advance in cancer treatment International Cancer Genome Consortium plans to sequence 25000 cancer genomes Scientists uncovering cancer causing genes |
 Live-PR.com (press release) | Monoclonal Antibodies Promise New Chances For Ovarian Cancer Therapy: Research ... Pharmaceutical Business Review In laboratory tests, scientists have reportedly succeeded in reducing the resistance of ovarian cancer tumor cells to a natural resistance mechanism with ... Fight-or-Flight Hormones Help Tumor Cells Escape to Spread Antibody offers new hope against ovarian cancer New Enemy Against Ovarian Cancer |
AACR Acknowledges Minority Leaders with Minority-Serving Institution Faculty ... Newswise (press release) Targeting the survin splice variant 2B in taxane-resistant ovarian cancer. Abstract #5468. JNK-1 Inhibition leads to antitumor activity in ovarian cancer. ... Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical ... Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical ... www.StockHunter.us: Great News For Our Subscibers!! IWEB,AMGN,SMCI: Sign Up ... |
NexMed and Angstrom Pharmaceuticals to Present Data on A6 Drug at AACR MarketWatch (press release) ... in vivo studies," covers pre-clinical work completed by Bio-Quant on Angstrom's lead product, A6, currently in Phase 2 development for ovarian cancer. ... |